These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 38787079)

  • 21. Uremic Toxins and their Relation to Dialysis Efficacy.
    Clark WR; Dehghani NL; Narsimhan V; Ronco C
    Blood Purif; 2019; 48(4):299-314. PubMed ID: 31563911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulated oxygen metabolism of the kidney by uremic toxins: review.
    Chiang CK; Tanaka T; Nangaku M
    J Ren Nutr; 2012 Jan; 22(1):77-80. PubMed ID: 22200419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of uremic toxin research by mass spectrometry.
    Niwa T
    Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Evolving View of Uremic Toxicity.
    Meijers B; Lowenstein J
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uremic toxicity: present state of the art.
    Vanholder R; Argilés A; Baurmeister U; Brunet P; Clark W; Cohen G; De Deyn PP; Deppisch R; Descamps-Latscha B; Henle T; Jorres A; Massy ZA; Rodriguez M; Stegmayr B; Stenvinkel P; Wratten ML
    Int J Artif Organs; 2001 Oct; 24(10):695-725. PubMed ID: 11817319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence.
    Chen JH; Chiang CK
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
    Reis T; Hutchison C; de Assis Rocha Neves F; Zawadzki B; Zanella M; Ronco C; Rosner MH
    Blood Purif; 2023; 52(3):242-254. PubMed ID: 36657410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly of chemically modified protein nanocages into 3D materials for the adsorption of uremic toxins.
    Böhler H; Orth-Alampour S; Baaten C; Riedner M; Jankowski J; Beck T
    J Mater Chem B; 2022 Dec; 11(1):55-60. PubMed ID: 36504125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the uremic toxins using proteomic technologies.
    Schiffer E; Mischak H; Vanholder RC
    Contrib Nephrol; 2008; 160():159-171. PubMed ID: 18401168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
    Gordon A; Berström J; Fürst P; Zimmerman L
    Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
    [No Abstract]   [Full Text] [Related]  

  • 39. Uremic toxins, and their effect on intermediary metabolism.
    Wills MR
    Clin Chem; 1985 Jan; 31(1):5-13. PubMed ID: 3880681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.
    Moradi H; Sica DA; Kalantar-Zadeh K
    Am J Nephrol; 2013; 38(2):136-48. PubMed ID: 23941724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.